Extract from the Register of European Patents

EP About this file: EP0533862

EP0533862 - RECOMBINANT HUMAN FACTOR VIII DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.08.2000
Database last updated on 01.04.2026
Most recent event   Tooltip25.08.2000No opposition filed within time limitpublished on 11.10.2000 [2000/41]
Applicant(s)For all designated states
Pharmacia & Upjohn Aktiebolag
112 87 Stockholm / SE
[1997/50]
Former [1995/02]For all designated states
Pharmacia AB (reg.number 556131-9608)
S-171 97 Stockholm / SE
Former [1993/13]For all designated states
KABI PHARMACIA AB
S-751 82 Uppsala / SE
Inventor(s)01 / ALMSTEDT, Annelie, B.
Tegnérgatan 45
S-111 61 Stockholm / SE
02 / HELLSTRÖM, Eva, Maria
Bergsgatan 3
S-112 23 Stockholm / SE
03 / LIND, Peter
Ringgatan 47C
S-752 27 Uppsala / SE
04 / LJUNG, Catherine
Basgränd 17
S-162 46 Vällingby / SE
05 / SANDBERG, Helena, Inga
Igelkottsvägen 21
S-161 37 Bromma / SE
06 / SPIRA, Jack
Tottvägen 6
S-171 35 Stockholm / SE
07 / SYDOW-BÄCKMAN, Mona
Knopvägen 1
S-133 44 Saltsjöbaden / SE
08 / WIMAN, Helena
Krukmakargatan 27
S-118 51 Stockholm / SE
[1993/13]
Representative(s)Burman, Tore, et al
AWAPATENT AB, Box 45086
104 30 Stockholm / SE
[N/P]
Former [1997/50]Burman, Tore, et al
AWAPATENT AB, Box 45086
104 30 Stockholm / SE
Former [1995/02](deleted)
Former [1994/32]Burman, Tore, et al
AWAPATENT AB, Box 45086
S-104 30 Stockholm / SE
Former [1993/13]Burman, Tore
Awapatent AB Box 45086
S-104 30 Stockholm / SE
Application number, filing date92905708.111.03.1992
[1993/13]
WO1992SE00150
Priority number, dateSE1991000079915.03.1991         Original published format: SE 9100799
[1993/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9216557
Date:01.10.1992
Language:EN
[1992/25]
Type: A1 Application with search report 
No.:EP0533862
Date:31.03.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.1992 takes the place of the publication of the European patent application.
[1993/13]
Type: B1 Patent specification 
No.:EP0533862
Date:27.10.1999
Language:EN
[1999/43]
Search report(s)International search report - published on:SE01.10.1992
ClassificationIPC:C07K14/00, C12N15/12, C12P21/02
[1998/47]
CPC:
C07K14/755 (EP); A61P7/04 (EP)
Former IPC [1993/13]C07K13/00, C12N15/12, C12P21/02
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   SE [1993/13]
TitleGerman:REKOMBINANTE DERIVATE DES MENSCHLICHEN FAKTORS VIII[1993/13]
English:RECOMBINANT HUMAN FACTOR VIII DERIVATIVES[1993/13]
French:DERIVES DU FACTEUR HUMAIN VIII RECOMBINE[1993/13]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase19.10.1992National basic fee paid 
19.10.1992Designation fee(s) paid 
19.10.1992Examination fee paid 
Examination procedure19.10.1992Examination requested  [1993/13]
26.02.1998Despatch of a communication from the examining division (Time limit: M06)
05.08.1998Reply to a communication from the examining division
16.12.1998Despatch of communication of intention to grant (Approval: No)
15.04.1999Despatch of communication of intention to grant (Approval: later approval)
27.04.1999Communication of intention to grant the patent
25.06.1999Fee for grant paid
25.06.1999Fee for publishing/printing paid
Opposition(s)28.07.2000No opposition filed within time limit [2000/41]
Fees paidRenewal fee
09.03.1994Renewal fee patent year 03
09.03.1995Renewal fee patent year 04
08.03.1996Renewal fee patent year 05
12.03.1997Renewal fee patent year 06
10.03.1998Renewal fee patent year 07
11.03.1999Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]   Proc. Natl. Acad. Sci., Vol. 83, May 1986, L.O. ANDERSSON: "Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentrate, cryoprecipitate and plasma", see pages 2979-2983. [X]
 [A]   The Journal of Biological Chemistry, 261(1986):27, R.L. BURKE et al., "The Functional Domains of Coagulation Factor VIII:C", pages 12574-12578. [A]
 [A]   Biochemistry, Vol. 25, No. 26, December 1986, D.L. EATON et al.: "Construction and Characterization of an Active Factor VIII variant Lacking the central One-Third of the Molecule", see pages 8343-8347. [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.